Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India.
South Asian J Cancer
; 10(4): 213-219, 2021 Dec.
Article
en En
| MEDLINE
| ID: mdl-34984198
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
South Asian J Cancer
Año:
2021
Tipo del documento:
Article
País de afiliación:
India